Clinical Trial

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-02-16; most recent amendment 2026-02-05.
Status change: Enrolling by Invitation → Recruiting 2024-07-15
Trial Details
NCT Number NCT05745389
Lead Sponsor CorEvitas
Conditions Alopecia Areata
Enrollment 5,000 participants
Start Date 2022-10-25
Primary Completion 2099-12-31 (estimated)
Study Completion 2099-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-09